Novo Nordisk
NVO
#107
Rank
C$239.02 B
Marketcap
C$54.23
Share price
-2.70%
Change (1 day)
-19.25%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

ESG Reports

Thumbnail Novo Nordisk ESG Report 2024

ESG Report 2024

Language: English

View ESG Report